Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150742 · ClinicalTrials.gov registry record · NA
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
A NA study of Acute Kidney Injury, sponsored by Talphera.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 10
- Study locations
NCT06150742 is a NA study of Acute Kidney Injury that is actively recruiting participants, run by Talphera. The registered enrollment target is 70 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 9 states.
The verdict
NCT06150742, a NA study of Acute Kidney Injury, is actively recruiting participants, sponsored by Talphera.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 10
- Study locations
Study Summary
A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for bleeding.
Conditions Studied
Interventions
- DEVICE Niyad (nafamostat mesylate)
- DEVICE Placebo (0.9% NaCl)
Study Locations (10)
New York
- Northwell Health - Great Neck
- Mount Sinai - New York
California
- University of California Los Angeles - Los Angeles
Florida
- AdventHealth - Orlando
Michigan
- Henry Ford Health - Detroit
New Mexico
- University of New Mexico - Albuquerque
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-08-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06150742
The ClinicalTrials.gov registry entry for NCT06150742 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (97% lower). The listed sponsor is Talphera, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 2 interventions - of which Niyad (nafamostat mesylate) is the first listed.
NCT06150742 reports 10 study locations spanning 9 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06150742 about?
NCT06150742 is a clinical study titled "Nafamostat Efficacy in Phase 3 Registrational CRRT Study". A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for bleed...
What is the current status of trial NCT06150742?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-08-15. Estimated completion is 2025-12.
What conditions does trial NCT06150742 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT06150742?
The interventions under investigation include: Niyad (nafamostat mesylate) (DEVICE), Placebo (0.9% NaCl) (DEVICE).
Who is sponsoring clinical trial NCT06150742?
This trial is sponsored by Talphera, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06150742 being conducted?
This trial has 10 study locations across California, Florida, Michigan, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
RECRUITING · NA
-
CTSN Embolic Protection Trial
RECRUITING · NA
-
A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
RECRUITING · NA
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
RECRUITING · NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.